Payer+Provider's Health System Review
A unified framework to account for selective mortality in lifecycle analyses of the social gradient in health
FDA authorizes Genentech’s Actemra to treat COVID-19 in hospitalized patients
June 25, 2021
Read the full post on Becker's Hospital Review - Healthcare News
